Back to resultsMessage Communicating Latest Data on COVID-19 Transmission in Patient's Area
Primary Purpose
COVID-19
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
COVID Booster text messages
Sponsored by
About this trial
This is an interventional health services research trial for COVID-19 focused on measuring COVID-19, behavioral science interventions, vaccination promotion
Eligibility Criteria
Exclusion Criteria: The patient unsubscribed from texts before the send date and time of the patient's SMS/MMS message The patient received a bivalent COVID booster before the send date and time of the patient's SMS/MMS message.
Sites / Locations
- University of Pennsylvania
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Control condition with "waiting for you" message
Message communicating latest data on COVID transmission in patient's area
Arm Description
This control condition will use the text message that the investigators found to be the best performing in their last mega-study of vaccine text messages to recommend a COVID vaccination.
This condition will use a text message informing the participant of the latest data on COVID transmission in participant's area and recommend a COVID vaccination.
Outcomes
Primary Outcome Measures
Patient uptake of COVID bivalent booster
Whether patients receive a bivalent COVID booster at the pharmacy in question
Secondary Outcome Measures
Patient uptake of COVID bivalent booster
Whether patients receive a bivalent COVID booster at the pharmacy in question
Patient uptake of COVID bivalent booster
Whether patients receive a bivalent COVID booster at the pharmacy in question
Full Information
NCT ID
NCT05621226
First Posted
November 16, 2022
Last Updated
March 1, 2023
Sponsor
University of Pennsylvania
1. Study Identification
Unique Protocol Identification Number
NCT05621226
Brief Title
Message Communicating Latest Data on COVID-19 Transmission in Patient's Area
Official Title
Message Communicating Latest Data on COVID-19 Transmission in Patient's Area
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
November 3, 2022 (Actual)
Primary Completion Date
December 8, 2022 (Actual)
Study Completion Date
February 6, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pennsylvania
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination by communicating to patients that they live in an area with significant COVID transmission and a control message telling patients that an updated COVID booster vaccine is waiting for them.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19
Keywords
COVID-19, behavioral science interventions, vaccination promotion
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Participants will be randomly assigned to the different arms.
Masking
Care ProviderOutcomes Assessor
Masking Description
As treated participants will receive text messages, there is no scope for blinding. Care providers will not be made aware of subjects' participation in the study, or assigned treatment arms. The study team will only receive data on subjects' assigned arms and outcomes at the end of the study.
Allocation
Randomized
Enrollment
520000 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control condition with "waiting for you" message
Arm Type
Experimental
Arm Description
This control condition will use the text message that the investigators found to be the best performing in their last mega-study of vaccine text messages to recommend a COVID vaccination.
Arm Title
Message communicating latest data on COVID transmission in patient's area
Arm Type
Experimental
Arm Description
This condition will use a text message informing the participant of the latest data on COVID transmission in participant's area and recommend a COVID vaccination.
Intervention Type
Behavioral
Intervention Name(s)
COVID Booster text messages
Intervention Description
Participants will receive text messages per descriptions listed in the arms.
Primary Outcome Measure Information:
Title
Patient uptake of COVID bivalent booster
Description
Whether patients receive a bivalent COVID booster at the pharmacy in question
Time Frame
During the 30 days after receiving the SMS/MMS intervention
Secondary Outcome Measure Information:
Title
Patient uptake of COVID bivalent booster
Description
Whether patients receive a bivalent COVID booster at the pharmacy in question
Time Frame
60 days after receiving the SMS/MMS intervention
Title
Patient uptake of COVID bivalent booster
Description
Whether patients receive a bivalent COVID booster at the pharmacy in question
Time Frame
90 days after receiving the SMS/MMS intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Exclusion Criteria:
The patient unsubscribed from texts before the send date and time of the patient's SMS/MMS message
The patient received a bivalent COVID booster before the send date and time of the patient's SMS/MMS message.
Facility Information:
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Message Communicating Latest Data on COVID-19 Transmission in Patient's Area
We'll reach out to this number within 24 hrs